Extracorporeal Cardiac Shock Wave Therapy (CSWT) for Treatment of Coronary Artery Disease in China

1
Guo Tao
Guo Tao
2
Wang Yu
Wang Yu
3
Peng Yunzhu
Peng Yunzhu
4
Yang Ping
Yang Ping
5
Cai Hong Yan
Cai Hong Yan
6
Tao Siming
Tao Siming
1 The first hospital of Kunming Medical University
2 Chongqing Medical University

Send Message

To: Author

GJMR Volume 14 Issue I4

Article Fingerprint

ReserarchID

5Y33H

Extracorporeal Cardiac Shock Wave Therapy (CSWT) for Treatment of Coronary Artery Disease in China Banner
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu

Coronary artery disease (CAD) is a leading cause of mortality worldwide. Common therapies in the treatment of CAD are invasive, insufficient and pose additional risks in patients with advanced refractory CAD. Cardiac shock wave therapy (CSWT) is a safe and effective noninvasive intervention in the management of patients with refractory CAD. In this article, we briefly outline our work in animals and humans, and discuss the advantages and perspectives of CSWT in China.

22 Cites in Articles

References

  1. Takahiro Nishida,Hiroaki Shimokawa,Keiji Oi,Hideki Tatewaki,Toyokazu Uwatoku,Kohtaro Abe,Yasuharu Matsumoto,Noriyoshi Kajihara,Masataka Eto,Takehisa Matsuda,Hisataka Yasui,Akira Takeshita,Kenji Sunagawa (2004). Extracorporeal Cardiac Shock Wave Therapy Markedly Ameliorates Ischemia-Induced Myocardial Dysfunction in Pigs in Vivo.
  2. T Uwatoku,K Ito,A Kohtaro,K Oi,T Hizume,K Sunagawa,H Shimokawa (2007). Extracorporeal cardiac shock wave therapy improves left ventricular remodeling after acute myocardial infarction in pigs.
  3. Yoshihiro Fukumoto,Akira Ito,Toyokazu Uwatoku,Tetsuya Matoba,Takuya Kishi,Haruki Tanaka,Akira Takeshita,Kenji Sunagawa,Hiroaki Shimokawa (2006). Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease.
  4. H Shimokawa,K Ito,Y Fukumoto,S Yasuda (2008). Extracorporeal cardiac shock wave therapy for ischemic heart disease.
  5. A Khattab,B Brodersen,D Schuermann-Kuchenbrandt,H Beurich,R Tölg,V Geist,T Schäfer,G Richardt (2007). Extracorporeal cardiac shock wave therapy: first experience in the everyday practice for treatment of chronic refractory angina pectoris.
  6. C Prinz,O Lindner,T Bitter,D Hering,W Burchert,D Horstkotte,L Faber (2009). Extracorporeal cardiac shock wave therapy ameliorates clinical symptoms and improves regional myocardial blood flow in a patient with severe coronary artery disease and refractory angina.
  7. A Gutersohn,G Caspari,R Erbel (2000). Upregulation of Vascular Endothelial Growth Factor m-RNA in Human Umbilical Vascular Endothelial Cells Via Shock Waves.
  8. Kenta Ito,Yoshihiro Fukumoto,Hiroaki Shimokawa (2009). Extracorporeal Shock Wave Therapy as a New and Non-invasive Angiogenic Strategy.
  9. Yoku Kikuchi,Kenta Ito,Yoshitaka Ito,Takashi Shiroto,Ryuji Tsuburaya,Kentaro Aizawa,Kiyotaka Hao,Yoshihiro Fukumoto,Jun Takahashi,Morihiko Takeda,Masaharu Nakayama,Satoshi Yasuda,Shinichi Kuriyama,Ichiro Tsuji,Hiroaki Shimokawa (2010). Double-Blind and Placebo-Controlled Study of the Effectiveness and Safety of Extracorporeal Cardiac Shock Wave Therapy for Severe Angina Pectoris.
  10. Y Vasyuk,A Hadzegova,E Shkolnik (2007). Extracorporeal cardiac shock wave therapy: first experience in the everyday practice for treatment of chronic refractory angina pectoris.
  11. Hiroaki Shimokawa,Kenta Ito,Yoshihiro Fukumoto,Satoshi Yasuda (2008). Extracorporeal cardiac shock wave therapy for ischemic heart disease.
  12. H Cai,Y Wang,L Li (2010). Changes in the number of endothelial progenitor cells from peripheral blood in patients with coronary atherosclerotic heart disease before and after extracorporeal cardiac shock wave therapy.
  13. H Cai,Y Wang,L Li,L Zhao,X Yang,J Xiao,J Cao,X Yang,C Yang,T Guo (2010). e0388 Effect of endothelial progenitor cells from peripheral blood in patients with coronary heart disease before and after extracorporeal cardiac shock wave therapy.
  14. S Tao,T Guo,Y Wang (2010). Effects of low-energy extracorporeal shock wave on myocardial matrix metalloproteinase system and ischemic myocardial capillary density after acute myocardial infarction.
  15. S Tao,T Guo,Y Wang (2012). Effect of extracorporeal cardiac shock wave therapy on left Engineering.
  16. S Sun,T Guo (2010). Effects of Extracorporeal Cardiac Shock Wave Therapy on Expression of Endothelial Nitric Oxide Synthase and Basic Fibroblast Growth Factor in Swine with Acute Myocardial Infarction.
  17. S Sun,T Guo (2010). Cardioprotective role of myocardial endothelial nitric oxide synthase and serum nitric oxide induced by hexarelin in rats with myocardial infarction-induced heart failure.
  18. Shuai Sun,Tao Guo (2010). e0221 Effects of extracorporeal cardiac shock wave therapy on expression of endothelial nitric oxide synthase and basic fibroblast growth factor in swine with acute myocardial infarction.
  19. Yu Wang,Tao Guo,Hong‐yan Cai,Tie‐kun Ma,Si‐ming Tao,Shuai Sun,Ming‐qing Chen,Yun Gu,Jia‐hua Pang,Jian‐ming Xiao,Xi‐yun Yang,Chao Yang (2010). Cardiac Shock Wave Therapy Reduces Angina and Improves Myocardial Function in Patients With Refractory Coronary Artery Disease.
  20. Yu Wang,Tao Guo,Tie-Kun Ma,Hong-Yan Cai,Si-Ming Tao,Yun-Zhu Peng,Ping Yang,Ming-Qing Chen,Yun Gu (2010). A modified regimen of extracorporeal cardiac shock wave therapy for treatment of coronary artery disease.
  21. P Yang,T Guo,W Wang (2012). Randomized and double-blind controlled clinical trial of extra corporeal cardiac shock wave therapy for coronary heart disease.
  22. Y Peng,T Guo,P Yang (2012). Effects of extracorporeal cardiac shock wave therapy in patients with ischemic heart failure.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

Guo Tao. 2014. \u201cExtracorporeal Cardiac Shock Wave Therapy (CSWT) for Treatment of Coronary Artery Disease in China\u201d. Unknown Journal GJMR-I Volume 14 (GJMR Volume 14 Issue I4): .

Download Citation

Journal Specifications
Classification
Not Found
Version of record

v1.2

Issue date

October 17, 2014

Language

English

Experiance in AR

The methods for personal identification and authentication are no exception.

Read in 3D

The methods for personal identification and authentication are no exception.

Article Matrices
Total Views: 4222
Total Downloads: 2214
2026 Trends
Research Identity (RIN)
Related Research

Published Article

Coronary artery disease (CAD) is a leading cause of mortality worldwide. Common therapies in the treatment of CAD are invasive, insufficient and pose additional risks in patients with advanced refractory CAD. Cardiac shock wave therapy (CSWT) is a safe and effective noninvasive intervention in the management of patients with refractory CAD. In this article, we briefly outline our work in animals and humans, and discuss the advantages and perspectives of CSWT in China.

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]
×

This Page is Under Development

We are currently updating this article page for a better experience.

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Extracorporeal Cardiac Shock Wave Therapy (CSWT) for Treatment of Coronary Artery Disease in China

Wang Yu
Wang Yu Chongqing Medical University
Peng Yunzhu
Peng Yunzhu
Yang Ping
Yang Ping
Cai Hong Yan
Cai Hong Yan
Tao Siming
Tao Siming
Guo Tao
Guo Tao The first hospital of Kunming Medical University

Research Journals